Thus, our study not only led to the discovery of the pleiotropic signaling of TS regulation by ANT2 and PHB2 but also constitutes a starting point for the design of novel TS targeting agents based on rabdosianone I analogs to provide opportunities for cancer treatment and prevention. This evidence concerns the gene SLC25A5 and cancer.